Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
ATLANTA, September 23, 2026--Accelerant Announces Expiration of "Go-Shop" Period
Aroa Biosurgery Limited (ASX: ARX), a soft tissue regeneration company, today announced the peer-reviewed publication of interim results from its ongoing MASTRR Registry, reporting low infection rates and no adverse events definitely related to Myriad products.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.